Luken Investment Analytics’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$170K Hold
436
0.06% 66
2026
Q1
$206K Sell
436
-59
-12% -$29.7K 0.08% 55
2025
Q4
$231K Buy
495
+2
+0.4% +$929 0.09% 50
2025
Q3
$210K Sell
493
-55
-10% -$21.3K 0.08% 53
2025
Q2
$210K Hold
548
0.09% 48
2025
Q1
$189K Hold
548
0.09% 48
2024
Q4
$164K Sell
548
-392
-42% -$137K 0.08% 51
2024
Q3
$382K Hold
940
0.18% 40
2024
Q2
$302K Hold
940
0.15% 41
2024
Q1
$314K Hold
940
0.16% 40
2023
Q4
$254K Hold
940
0.14% 42
2023
Q3
$231K Hold
940
0.13% 42
2023
Q2
$285K Hold
940
0.16% 38
2023
Q1
$248K Hold
940
0.15% 37
2022
Q4
$226K Buy
+940
New +$211K 0.14% 36
2020
Q4
$99K Buy
+600
New +$87.7K 0.07% 38

Other funds holding HCA

Luken Investment Analytics's HCA Position: Q2 2026 in Review

Luken Investment Analytics held its HCA Healthcare (HCA) position steady in Q2 2026 at 436 shares worth $170K. The position accounts for 0.06% of the portfolio, ranked #66.

Luken Investment Analytics first reported a position in HCA in Q4 2020 and has held it in 16 quarters since. The position peaked at $382K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Luken Investment Analytics held 436 shares of HCA Healthcare worth $170K as of Q2 2026.
  • Luken Investment Analytics left its HCA Healthcare share count unchanged in Q2 2026.
  • HCA Healthcare made up 0.06% of Luken Investment Analytics's portfolio in Q2 2026, its #66 holding.
  • Luken Investment Analytics first reported a position in HCA Healthcare in Q4 2020 and has held it in 16 quarters since.
  • Luken Investment Analytics's HCA Healthcare position peaked at $382K in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Luken Investment Analytics's 13F filing for Q2 2026, filed 28 Jul 2026.